AU2002353366A1 - The process of manufacturing a pharmaceutical composition useful for management of cancer - Google Patents

The process of manufacturing a pharmaceutical composition useful for management of cancer

Info

Publication number
AU2002353366A1
AU2002353366A1 AU2002353366A AU2002353366A AU2002353366A1 AU 2002353366 A1 AU2002353366 A1 AU 2002353366A1 AU 2002353366 A AU2002353366 A AU 2002353366A AU 2002353366 A AU2002353366 A AU 2002353366A AU 2002353366 A1 AU2002353366 A1 AU 2002353366A1
Authority
AU
Australia
Prior art keywords
cancer
management
manufacturing
pharmaceutical composition
composition useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002353366A
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002353366A1 publication Critical patent/AU2002353366A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002353366A 2001-12-10 2002-12-10 The process of manufacturing a pharmaceutical composition useful for management of cancer Abandoned AU2002353366A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1166/MUM/2001 2001-12-10
IN1166MU2001 2001-12-10
PCT/IB2002/005515 WO2003049751A1 (en) 2001-12-10 2002-12-10 The process of manufacturing a pharmaceutical composition useful for management of cancer

Publications (1)

Publication Number Publication Date
AU2002353366A1 true AU2002353366A1 (en) 2003-06-23

Family

ID=11097333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002353366A Abandoned AU2002353366A1 (en) 2001-12-10 2002-12-10 The process of manufacturing a pharmaceutical composition useful for management of cancer

Country Status (2)

Country Link
AU (1) AU2002353366A1 (en)
WO (1) WO2003049751A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
AU2005251397B2 (en) * 2004-06-07 2010-11-11 Qu Biologics Inc. Bacterial compositions for the treatment of cancer
WO2008114119A2 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
WO2009001204A2 (en) * 2007-06-28 2008-12-31 Cadila Pharmaceuticals Ltd. Mitogen activated protein kinase modulator
KR102157718B1 (en) 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 Immunogenic anti-inflammatory compositions
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
EP2663318B1 (en) * 2011-01-11 2015-03-18 Cadila Pharmaceuticals Ltd. Pharmaceutical composition for treating cancer
EP3424523A1 (en) * 2011-02-28 2019-01-09 Cadila Pharmaceuticals Ltd. Therapeutic cancer vaccine
GB201120779D0 (en) 2011-12-02 2012-01-11 Immodulon Therapeutics Ltd Cancer therapy
GB201322725D0 (en) 2013-12-20 2014-02-05 Immodulon Therapeutics Ltd Cancer therapy
WO2015164979A1 (en) 2014-05-02 2015-11-05 Qu Biologics Inc. Anti-microbial immunomodulation
MX2017016931A (en) 2015-06-24 2018-09-26 Immodulon Therapeutics Ltd A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5513204A (en) * 1978-06-28 1980-01-30 Mitsui Toatsu Chem Inc Active compound having delayed allergic activity and anticarcinogenic activity, and its preparation
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
FR2662942B1 (en) * 1990-06-06 1992-09-18 Neway Tsehay IMMUNOSTIMULATING MEDICINE BASED ON POLAR GLYCOPEPTIDOLIPIDES OF MYCOBACTERIUM CHELONAE.
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
NZ505834A (en) * 1997-12-23 2002-12-20 Genesis Res & Dev Corp Ltd Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use

Also Published As

Publication number Publication date
WO2003049751A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
AU2002353366A1 (en) The process of manufacturing a pharmaceutical composition useful for management of cancer
AU2002366771A1 (en) Mold for producing shoe-sole
AU2002358921A1 (en) Novel drug targets for arthritis
AU2001240664A1 (en) Process for the production of methionine
AU2002310034A1 (en) Process for the preparation of 3-hydroxypropanal
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU2002335992A1 (en) Process for the production of ascopyrone p
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU2002342940A1 (en) New pharmaceutical compounds
AU2002357611A1 (en) Coated tablets and process for producing the same
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2003223104A1 (en) A process for the preparation of indolymaleimides
AU2002352423A1 (en) Process for the manufacture of pharmaceutically acceptable salts of a compound
AU2001279511A1 (en) Process for obtaining a pharmaceutical composition
AU2002352014A1 (en) Method for the production of organodiphosphonites
EP1386911A3 (en) Process for the preparation of acyloxybenzenesulfonates
AUPR144100A0 (en) Process for can manufacture
AU2002344645A1 (en) Process for producing bisbenzil compounds
AU2002314365A1 (en) Process for the production of allicin
AU2002340149A1 (en) Process for manufacturing fertilizer
AUPR738001A0 (en) Compound for medicinal purposes
AU2002336303A1 (en) Novel compounds and process for their production
AU2002251115A1 (en) Process for the production of xylitol
AU2002240925A1 (en) Process for the production of 6-methylheptanone

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase